Global Cell Counting Market Report

List of Tables

The global demand for Cell Counting Market is presumed to reach the market size of nearly USD 17.23 MN by 2030 from USD 8.3 MN in 2022 with a CAGR of 9.56% under the study period 2023 - 2030.

Cell counting is used to determine the concentration of cells for various purposes. It is used to assess cell viability after and before drug treatment, qualitatively determine the cell health or count subpopulations, and capture and analyze the data. Cell counting is done manually, or through an automatic counter to count live and/or dead cells in culture.

MARKET DYNAMICS:

The cell counting market growth is driven by increasing funding for cell-based research, majorly concentrated in developed countries. This is largely based on the high incidence rate of some chronic and infectious diseases, their detection and finding a cure or treatment. Many biotechnology and biopharmaceutical industries are investing heavily in the research and development in this field. Moreover, the technological advancement in improving image analysis and the growing use of high-throughput flow cytometry and automated haematology analyzers is anticipated to keep the market on the growth trend.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell counting. The growth and trends of cell counting industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cell counting market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Consumables And Accessories (Reagents, Microplates, Others)
Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, Cell Counters, Microscopes, Others)

By Application

Complete Blood Count (Automated Cell Counters, Manual Cell Counters)
Stem Cell Research
Cell Based Therapeutics
Bioprocessing
Toxicology
Others

By End Users

Research Institutes
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Other End Users

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cell Counting market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cell counting market include ThermoFisher Scientific Inc., Merck KGaA, Agilent Technologies, PerkinElmer Inc., BD, Danaher, Bio-Rad Laboratories Inc., BioTek Instruments Inc., GE Healthcare, DeNovix Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11218607

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CELL COUNTING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End Users
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL COUNTING MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Consumables And Accessories (Reagents, Microplates, Others) Historic and Forecast Sales by Regions
5.5 Instruments (Spectrophotometers, Flow Cytometers, Hematology Analyzers, Cell Counters, Microscopes, Others) Historic and Forecast Sales by Regions

6 . GLOBAL CELL COUNTING MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Complete Blood Count (Automated Cell Counters, Manual Cell Counters) Historic and Forecast Sales by Regions
6.5 Stem Cell Research Historic and Forecast Sales by Regions
6.6 Cell Based Therapeutics Historic and Forecast Sales by Regions
6.7 Bioprocessing Historic and Forecast Sales by Regions
6.8 Toxicology Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL CELL COUNTING MARKET ANALYSIS BY END USERS

7.1 Overview by End Users
7.2 Historical and Forecast Data
7.3 Analysis by End Users
7.4 Research Institutes Historic and Forecast Sales by Regions
7.5 Hospitals & Diagnostic Laboratories Historic and Forecast Sales by Regions
7.6 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
7.7 Other End Users Historic and Forecast Sales by Regions

8 . GLOBAL CELL COUNTING MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CELL COUNTING COMPANIES

9.1. Cell Counting Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF CELL COUNTING INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. ThermoFisher Scientific Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Merck KGaA
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Agilent Technologies
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. PerkinElmer Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. BD
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Danaher
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Bio-Rad Laboratories Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. BioTek Instruments Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. GE Healthcare
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. DeNovix Inc.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies